Blepharitis historical perspective

Revision as of 18:04, 27 July 2016 by Gerald Chi- (talk | contribs)
Jump to navigation Jump to search

Blepharitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Blepharitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Blepharitis historical perspective On the Web

recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Blepharitis historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Blepharitis historical perspective

CDC on Blepharitis historical perspective

Blepharitis historical perspective in the news

Blogs on Blepharitis historical perspective

Directions to Hospitals Treating Blepharitis

Risk calculators and risk factors for Blepharitis historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

Blepharitis was first described in the 19th century as "conjunctivitis meibomianae" in a patient with accumulated sebaceous-like material in the meibomian glands.

Historical Perspective

The terminology for blepharitis has evolved alongside the discovery of its pathophysiology and treatment. Early terms used to describe related meibomian gland conditions include ophthalmia tarsi, puriform palpebral flux, polyadenitis meibomiana chronica suppurativa, conjunctivitis meibomianae, meibomian seborrhea, keratitis meibomiana, seborrheic blepharoconjunctivitis, meibomian keratoconjunctivitis, meibomianitis, meibomitis, and meibomian gland dysfunction.

The earliest description of blepharitis dates back to 1894, when Lydston reported the clinical entity "conjunctivitis meibomianae" in a patient with accumulated sebaceous-like material in the meibomian glands.[1]

In 1901, Maklahoff reported a case characterized by dilated meibomian gland openings with pus formation in the glands.[2]

In 1908, Elschnig described the symptom of meibomian gland hypersecretion which could be relieved by emptying of the glands and the use of astringents.[3]

In 1921, Gifford isolated Staphylococcus aureus and Bacillus xerosis from meibomian gland cultures of young and elderly individuals, respectively.[4] This finding suggested that colonization of microorganisms in the meibomian glands may play a role in the pathogenesis.

In 1946, Thygeson proposed a classification of blepharitis based on the etiology: 1) seborrheic, 2) staphylococcal, 3) mixed seborrheic and staphylococcal, and 4) blepharitis due to Hemophilus duplex.[5]

  • In 1946, a combination of antimicrobial therapy and eyelid hygiene was first used by Phillips Thygeson, M.D.[6][7]

References

  1. LYDSTON, JAMES A. "CONJUNCTIVITIS MEIBOMIANÆ." Journal of the American Medical Association 23.6 (1894): 241-242.
  2. Maklahoff, AA. "Zur Bactderchron eitrigen Entzund der Gland Meib des Lides." Arch fur Augenheilkd. 1901;13:10.
  3. Elschnig, A. "Beitrag zur Aethiologie und Therapie der cronischen Konjunctivitis." Deuts Med Wochenschr 26 (1908): 1133-1135.
  4. Gifford, Sanford R. "The etiology of chronic meibomitis." American Journal of Ophthalmology 4.8 (1921): 566-570.
  5. Thygeson, Phillips. "Etiology and treatment of blepharitis: a study in military personnel." Archives of Ophthalmology 36.4 (1946): 445-477.
  6. THYGESON P, VAUGHAN DG (1954). "Seborrheic blepharitis". Trans Am Ophthalmol Soc. 52: 173–88. PMC 1312591. PMID 13274422.
  7. THYGESON P (1946). "Etiology and treatment of blepharitis; a study in military personnel". Arch Ophthal. 36 (4): 445–77. PMID 21002032.